NEW YORK , Nov. 14, 2022 /PRNewswire/ -- The "Animal Sedative Market by Type and Geography - Forecast and Analysis 2022-2026" report has been added to Technavio's offering. The report expects the market size to grow by USD 190.96 million, accelerating at a CAGR of 5.85% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. Technavio offers an up-to-date analysis of the current global market scenario and the overall market environment. Download a Free PDF Sample Report
Animal Sedative Market 2022-2026: Scope
Some of the major vendors of the animal sedative market include Akorn Operating Co. LLC, AmerisourceBergen Corp, Bayer AG, Bimeda Inc., C. H. Boehringer Sohn AG and Co. KG, Ceva Sante Animale, Chanelle Pharma Group, Dechra Pharmaceuticals Plc, Elanco Animal Health Inc., Jurox Pty Ltd., Konig SA, Laboratorios Richmond, Merck KGaA, Modern Veterinary Therapeutics LLC, Randlab Pty Ltd., Troy Laboratories Pty Ltd., Virbac Group, Zoetis Inc., Orion Corp., and Ouro Fino Saude Animal Group. To help businesses improve their market position, Technavio's report provides a detailed analysis of around 25 vendors operating in the market. The Increasing prevalence of animal diseases will offer immense growth opportunities. To leverage the current opportunities, market vendors must strengthen their foothold in the fast-growing segments while maintaining their positions in the slow-growing segments.
The report also covers the following areas:
Technavio's library includes over 17,000+ reports covering more than 2,000 emerging
technologies. Subscribe to our "Basic Plan" at just USD 5,000 and get lifetime access to
our Technavio Insights
Animal Sedative Market 2022-2026: Segmentation
- Type
- Parenteral
- Oral
The market growth in the parenteral segment will be significant during the forecast period. Parenteral administration methods typically produce the highest bioavailability of drugs as they avoid the first-pass effect of hepatic metabolism, which frequently happens with orally delivered chemicals and medicines. Additionally, some of the uncertainty involved with enteral absorptive processes is avoided by using parenteral methods. Other factors driving the growth of the segment include the approval of animal sedatives by various agencies such as the FDA.
- Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
44% of the market growth will come from North America during the forecast period. The growth of the regional market can be attributed to factors such as an increase in the frequency of zoonotic diseases, the use of animal sedatives, and increased expenditure on animal medical research. Identify other potential segments in the market. Buy Now!
Animal Sedative Market 2022-2026: Key Highlights
- CAGR of the market during the forecast period 2022-2026
- Detailed information on factors that will assist animal sedative market growth during the next five years
- Estimation of the animal sedative market size and its contribution to the parent market
- Predictions on upcoming trends and changes in consumer behavior
- The growth of the animal sedative market
- Analysis of the market's competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of animal sedative market vendors
Related Reports:
- The Veterinary Eye Care Market share is expected to increase by USD 788.78 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 4.65%. The rising pet ownership is notably driving the veterinary eye care market growth, although factors such as the stringent regulatory approval process of drugs may impede the market growth.
- The Lice Treatment Market share is expected to increase by USD 128.97 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 6.26%. The increasing prevalence of lice infestation is notably driving the lice treatment market growth, although factors such as the high cost of healthcare may impede the market growth.
Animal Sedative Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.85% |
Market growth 2022-2026 |
USD 190.96 million |
Market structure |
Fragmented |
YoY growth (%) |
5.25 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 44% |
Key consumer countries |
US, Canada, Germany, UK, and China |
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
Companies profiled |
Akorn Operating Co. LLC, AmerisourceBergen Corp, Bayer AG, Bimeda Inc., C. H. Boehringer Sohn AG and Co. KG, Ceva Sante Animale, Chanelle Pharma Group, Dechra Pharmaceuticals Plc, Elanco Animal Health Inc., Jurox Pty Ltd., Konig SA, Laboratorios Richmond, Merck KGaA, Modern Veterinary Therapeutics LLC, Randlab Pty Ltd., Troy Laboratories Pty Ltd., Virbac Group, Zoetis Inc., Orion Corp., and Ouro Fino Saude Animal Group |
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Table of contents:
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 12: Market segments
- 3.3 Market size 2021
- 3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
- 4.2 Bargaining power of buyers
- Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
- 4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
- 4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
- 4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
- 4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
- 4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Type
- 5.1 Market segments
- Exhibit 24: Chart on Type - Market share 2021-2026 (%)
- Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
- 5.2 Comparison by Type
- Exhibit 26: Chart on Comparison by Type
- Exhibit 27: Data Table on Comparison by Type
- 5.3 Parenteral - Market size and forecast 2021-2026
- Exhibit 28: Chart on Parenteral - Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Parenteral - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Parenteral - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Parenteral - Year-over-year growth 2021-2026 (%)
- 5.4 Oral - Market size and forecast 2021-2026
- Exhibit 32: Chart on Oral - Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Oral - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Oral - Year-over-year growth 2021-2026 (%)
- 5.5 Market opportunity by Type
- Exhibit 36: Market opportunity by Type ($ million)
6 Customer Landscape
- 6.1 Customer landscape overview
- Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
- 7.1 Geographic segmentation
- Exhibit 38: Chart on Market share by geography 2021-2026 (%)
- Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
- 7.2 Geographic comparison
- Exhibit 40: Chart on Geographic comparison
- Exhibit 41: Data Table on Geographic comparison
- 7.3 North America - Market size and forecast 2021-2026
- Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
- 7.4 Europe - Market size and forecast 2021-2026
- Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
- 7.5 Asia - Market size and forecast 2021-2026
- Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
- 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- 7.7 US - Market size and forecast 2021-2026
- Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
- 7.8 Germany - Market size and forecast 2021-2026
- Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
- 7.9 UK - Market size and forecast 2021-2026
- Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
- 7.10 Canada - Market size and forecast 2021-2026
- Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
- 7.11 China - Market size and forecast 2021-2026
- Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
- 7.12 Market opportunity by geography
- Exhibit 78: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
- 8.1 Market drivers
- 8.2 Market challenges
- 8.3 Impact of drivers and challenges
- Exhibit 79: Impact of drivers and challenges in 2021 and 2026
- 8.4 Market trends
9 Vendor Landscape
- 9.1 Overview
- 9.2 Vendor landscape
- Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
- 9.3 Landscape disruption
- Exhibit 81: Overview on factors of disruption
- 9.4 Industry risks
- Exhibit 82: Impact of key risks on business
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 83: Vendors covered
- 10.2 Market positioning of vendors
- Exhibit 84: Matrix on vendor position and classification
- 10.3 Bayer AG
- Exhibit 85: Bayer AG - Overview
- Exhibit 86: Bayer AG - Business segments
- Exhibit 87: Bayer AG - Key offerings
- Exhibit 88: Bayer AG - Segment focus
- 10.4 C. H. Boehringer Sohn AG and Co. KG
- Exhibit 89: C. H. Boehringer Sohn AG and Co. KG - Overview
- Exhibit 90: C. H. Boehringer Sohn AG and Co. KG - Business segments
- Exhibit 91: C. H. Boehringer Sohn AG and Co. KG - Key news
- Exhibit 92: C. H. Boehringer Sohn AG and Co. KG - Key offerings
- Exhibit 93: C. H. Boehringer Sohn AG and Co. KG - Segment focus
- 10.5 Ceva Sante Animale
- Exhibit 94: Ceva Sante Animale - Overview
- Exhibit 95: Ceva Sante Animale - Product / Service
- Exhibit 96: Ceva Sante Animale - Key offerings
- 10.6 Dechra Pharmaceuticals Plc
- Exhibit 97: Dechra Pharmaceuticals Plc - Overview
- Exhibit 98: Dechra Pharmaceuticals Plc - Business segments
- Exhibit 99: Dechra Pharmaceuticals Plc - Key offerings
- Exhibit 100: Dechra Pharmaceuticals Plc - Segment focus
- 10.7 Elanco Animal Health Inc.
- Exhibit 101: Elanco Animal Health Inc. - Overview
- Exhibit 102: Elanco Animal Health Inc. - Product / Service
- Exhibit 103: Elanco Animal Health Inc. - Key offerings
- 10.8 Merck KGaA
- Exhibit 104: Merck KGaA - Overview
- Exhibit 105: Merck KGaA - Business segments
- Exhibit 106: Merck KGaA - Key news
- Exhibit 107: Merck KGaA - Key offerings
- Exhibit 108: Merck KGaA - Segment focus
- 10.9 Orion Corp.
- Exhibit 109: Orion Corp. - Overview
- Exhibit 110: Orion Corp. - Product / Service
- Exhibit 111: Orion Corp. - Key offerings
- 10.10 Ouro Fino Saude Animal Group
- Exhibit 112: Ouro Fino Saude Animal Group - Overview
- Exhibit 113: Ouro Fino Saude Animal Group - Product / Service
- Exhibit 114: Ouro Fino Saude Animal Group - Key offerings
- 10.11 Virbac Group
- Exhibit 115: Virbac Group - Overview
- Exhibit 116: Virbac Group - Business segments
- Exhibit 117: Virbac Group - Key news
- Exhibit 118: Virbac Group - Key offerings
- Exhibit 119: Virbac Group - Segment focus
- 10.12 Zoetis Inc.
- Exhibit 120: Zoetis Inc. - Overview
- Exhibit 121: Zoetis Inc. - Business segments
- Exhibit 122: Zoetis Inc. - Key news
- Exhibit 123: Zoetis Inc. - Key offerings
- Exhibit 124: Zoetis Inc. - Segment focus
11 Appendix
- 11.1 Scope of the report
- 11.2 Inclusions and exclusions checklist
- Exhibit 125: Inclusions checklist
- Exhibit 126: Exclusions checklist
- 11.3 Currency conversion rates for US$
- Exhibit 127: Currency conversion rates for US$
- 11.4 Research methodology
- Exhibit 128: Research methodology
- Exhibit 129: Validation techniques employed for market sizing
- Exhibit 130: Information sources
- 11.5 List of abbreviations
- Exhibit 131: List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
Share this article